- Report
- July 2025
- 46 Pages
United States
From €1059EUR$1,205USD£925GBP
- Report
- April 2025
- 49 Pages
United States
- Report
- April 2025
- 47 Pages
United States
- Report
- November 2024
- 78 Pages
Canada
From €817EUR$930USD£714GBP
- Report
- November 2023
- 102 Pages
Global
From €1318EUR$1,500USD£1,151GBP
- Webinar
- May 2023
- 60 Minutes
Global
From €132EUR$150USD£115GBP
- Webinar
- 60 Minutes
Global
From €132EUR$150USD£115GBP
- Report
- November 2024
- 90 Pages
Australia
From €1634EUR$1,859USD£1,427GBP
- Report
- November 2021
- 620 Pages
Global
From €3516EUR$4,000USD£3,070GBP
- Report
- June 2023
- 71 Pages
France
From €2070EUR$2,355USD£1,807GBP
- Report
- June 2023
- 88 Pages
China
From €1912EUR$2,175USD£1,669GBP
- Report
- June 2023
- 84 Pages
Germany
From €2070EUR$2,355USD£1,807GBP
- Report
- June 2023
- 73 Pages
South Korea
From €1912EUR$2,175USD£1,669GBP
The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more
